NCT03738683View on ClinicalTrials.gov

Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

October 1, 2019

Conditions
Bacterial Infections
Interventions
DRUG

Piperacillin/tazobactam

Dose according to summary of product characteristics (SPC) or local protocols

Trial Locations (2)

Unknown

Radboud University Medical Center, Nijmegen

University Medical Centre Utrecht, Utrecht

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

lead

Radboud University Medical Center

OTHER

NCT03738683 - Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients | Biotech Hunter | Biotech Hunter